Trump Administration

News

Nine more companies sign pricing deals with Trump

Nine more pharma groups have agreed to lower the costs of medicines in the US under the Trump administration's most favoured nation (MFN) scheme.

News

Pfizer CEO Albert Bourla shakes hands with President Donald Trump in the White House.

Trump, Pfizer announce MFN deal; Lilly, others to come

At the White House today, President Trump and Pfizer CEO Albert Bourla announced the first of many deals to secure MFN drug prices for US consumers.

Market Access

pharmaphorum podcast Episode 141, Alice Valder Curran

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

Alice Valder Curran, a partner at Hogan Lovells, provides an update on what's happening right now with Most Favoured Nations drug pricing.

Market Access

American flag waving with the Capitol Hill

Four months, 157 Executive Orders: Inside the science of Tru...

When Donald Trump returned to the White House in January 2025, the question wasn't whether his administration would change the direction of US health policy – it was how quickly, how deeply

Patients

executive stand up for global health - four faces with a world map overlayed

Op-ed: Pharma must show courage, leadership on public health

Pharma companies can't claim to care about global patient wellbeing unless they stand up to Trump's public health cuts.

Nine more companies sign pricing deals with Trump

Trump, Pfizer announce MFN deal; Lilly, others to come

Policy in focus: Trump’s Most Favoured Nations drug pricing ...

Four months, 157 Executive Orders: Inside the science of Tru...

Op-ed: Pharma must show courage, leadership on public health

23andMe study explains variable results with obesity drugs

Using AI-driven synthetic personas to take your insights fur...

Trump Administration

Editor's Picks